key: cord-0814221-7vw75phg authors: Costantino, A.; Noviello, D.; Mazza, S.; Berté, R.; Caprioli, F.; Vecchi, M. title: Trust in telemedicine from IBD outpatients during the COVID-19 pandemic date: 2020-11-05 journal: Dig Liver Dis DOI: 10.1016/j.dld.2020.10.035 sha: 19fc78cedb1c4debc78a7e724048e4dce5738e0a doc_id: 814221 cord_uid: 7vw75phg nan tient assistance, clinical monitoring and potentially some interven-9 tions [1] . Telemedicine is sometimes used as a synonym or it is 10 used in a more limited sense to describe remote clinical services. 11 Telemedicine had been spreading rapidly in the last few years. spite the technological revolution its applications are however lim- 13 ited primarily to generally asynchronous monitoring (e.g. text mes- 14 sages, e-mails) or telephone support. Synchronous (live) tools may 15 be more appreciated, as participants to a recent study indicated 16 that an email that is not promptly answered may lead to additional 17 frustration [2] . 18 During the recent SARS-CoV-2 (COVID-19) pandemic, telem- Maggiore Policlinico Foundation in Milan (Italy), which is a tertiary 36 referral center for IBD, we also embraced telemedicine, especially 37 as regards the use of video-consultations. 38 Telemedicine for IBD patients has been performed mainly 39 through asynchronous remote monitoring such as web-based plat-40 form symptom reporting, smartphone apps and text messages [7] . 41 Some positive reports on the use of telemedicine among health-42 care providers have been published [ 7 , 9 ] , but a patient's perspec-43 tive about patients' trust in telemedicine has been missing to date. 44 We designed a study to verify IBD patients' trust in 45 telemedicine. 46 During the COVID-19 pandemic video-consultations were per- were used according to the patient's preference. 78 We ended the enrolment upon reaching the hundredth cor-79 rectly compiled questionnaire. The statistical analysis was per-80 formed by SPSS. 81 We scheduled 123 video-consultations, of which 115 (93.4%) 82 were performed. Overall, 100 (86.9%) questionnaires were com-83 piled. 84 The patients' baseline characteristics are described in Table 2 . 85 Regarding the trust in the telemedicine service, items 5.1, 5.2 86 and 5.4 received a score of least 4 in 95%, 90% and 84%, respec-87 tively ( Fig. 1 Note. The primary endpoint was patients' trust in telemedicine. This was expressed as a percentage of patients greater than 75% giving a score of at least 4 out of 5 in a Likert Scale for three selected key statements: "I can trust video-consultation" (5.1), "I can trust that possible problems with the telemedicine service will be solved properly" (5.2) and "I feel at ease when working with this website" (5.4). The aim of this study was to evaluate for the first time the IBD 107 patients' trust in telemedicine, as its possible future deployment 108 depends particularly on such patients' acknowledgement. 109 The results of our report showed that the IBD patients in our 110 series trust telemedicine. It is worth noting that low trust in tech-111 nology (a score < 4 in more than 30%) did not affect telemedicine 112 trust, in contrast to the PATAT test validation study [10] . Secondly, young median age of 41 years should be taken into 130 account. IBD patients are usually younger than those suffering 131 from other chronic diseases (e.g. neurodegenerative or neoplas-132 tic). Younger people may be readier to embrace new technolo-133 gies. Moreover, our Hospital is located in the center of Milan, the 134 biggest city of northern Italy and the local economy heavily relies 135 on IT and other digital technology. Patients may have well been 136 used to operating telematic tools in their jobs. Can our results be 137 reproducible in other contexts (e.g. elderly patients, more rural ar-138 eas)? 139 Thirdly, there was no control group. Further randomized studies 140 could analyze how different telemedicine tools (e.g. e-mail, tele-141 phone calling, video-conferencing) affect patients' trust levels. 142 Nevertheless, our data shows a positive attitude of IBD patients 143 towards video-consultations. 144 Our good trust rate in video-consultations among IBD patients 145 is the fundamental pre-requisite for being confident to propose pa-146 tients this approach. This result increases our propensity to expand 147 telemedicine beyond the traditional ideal setting (i.e. young pa-148 tient, digital workers) and beyond the pandemic emergency con-149 text. 150 Whether this trust will survive the end of the COVID-19 pan-151 demic and how telemedicine should be better deployed will be 152 topics surely to be analyzed further on. None. Data sharing 166 The data underlying this article will be shared on reasonable 167 request to the corresponding author. 168 State of telehealth The return of the house call Risk factors for opportunis-176 tic infections in patients with inflammatory bowel disease Italian group for the study of inflammatory 181 bowel disease (IG-IBD). Outcomes of COVID-19 in 79 patients with IBD in Italy: 182 an IG-IBD study Publication/6 _ 8 _ Surveys/2nd _ Interview _ 184 COVID-19 _ ECCO _ Taskforce _ published Remote monitoring and telemedicine in IBD: are we there 186 yet? International organization for the study Q1 188 of inflammatory bowel disease. Innovation in inflammatory bowel disease care 189 during the COVID-19 pandemic: results of a global telemedicine survey by the 190 international organization for the study of inflammatory bowel disease Maintaining the quality standards of care 193 for inflammatory bowel disease patients during the COVID-19 pandemic Measuring patient trust in telemedicine ser-196 vices: development of a survey instrument and its validation for an anticoag-197 ulation web-service Granda Ospedale Q2